BMS to file for an injunction of generic sales prohibition against Dong-A ST

It was known that BMS has filed for an injunction to restrict sales against infringement of patent on Dong-A ST which has already launched a generic of ‘Baraclude,’ a mega-scale hepatitis B treatment, before its patent expiration.

This was a scheduled order. As surprisingly launching a Baraclude generic, ‘Baracle,’ Dong-A ST has had a high chance to be applied for the injection in purpose of s...